Skip to main content
. 2018 Nov 26;43(5):277–283. doi: 10.1080/01658107.2018.1542009

Table 4.

Adverse events associated with the botulin A toxin administration over the duration of the study.

Adverse Event (AE) Number (%)
Subjects with at least 1 AE 51 (39.2)
Ptosis 32 (24.6)
Haematoma 12 (9.2)
Dry Eye 2 (1.5)
Dysgeusia 1 (0.8)
Diplopia 7 (5.3)
Corneal Ulcer 1 (0.8)
Dysphagia * 4 (3.1)

Note. * Dysphagia is related to the need for cervical approach in some patients.